2013-08-22 Phase 2b/3 pivotal shingles trial to be focused on demonstrating key point of pain differentiation According to the FDA, Valtrex and Famvir have not shown any statistical differences compared to control for pain • Consequently, EPB-348 Phase 2b/3 trials can go against placebo for both a